DEA schedule
Is Metadate CD a controlled substance?
Metadate CD contains methylphenidate. Federal schedule from the FDA NDC directory, checked against the DEA controlled substances list.
Source: FDA NDC Directory file dated 2026-10-22. Publisher page
Yes. Metadate CD (methylphenidate) is a Schedule II controlled substance under the federal Controlled Substances Act. Matching DEA list entry: Methylphenidate (Schedule II).
Run it in Rivvi
Which 2027 plans near you dropped or restricted Metadate CD?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.
Schedule check
| Source | What it lists |
|---|---|
| FDA NDC directory | 12 prescription listings from 2 labelers, all Schedule II |
| DEA controlled substances list | Methylphenidate: Schedule II |
DEA list entry
| Substance | DEA code | Schedule | Narcotic | Other names | Match |
|---|---|---|---|---|---|
| Methylphenidate | 1724 | II | No | Concerta; Ritalin; Methylin | Listed by name |
Metadate CD NDC listings
| NDC | Product | Form | Strength | Labeler | DEA schedule |
|---|---|---|---|---|---|
| 0527-6579 | METADATE CD | capsule, extended release | 10 mg/1 | Lannett Company, LLC | CII |
| 69654-579 | METADATE CD | capsule, extended release | 10 mg/1 | Aytu BioPharma, Inc. | CII |
| 0527-6580 | METADATE CD | capsule, extended release | 20 mg/1 | Lannett Company, LLC | CII |
| 69654-580 | METADATE CD | capsule, extended release | 20 mg/1 | Aytu BioPharma, Inc. | CII |
| 0527-6581 | METADATE CD | capsule, extended release | 30 mg/1 | Lannett Company, LLC | CII |
| 69654-581 | METADATE CD | capsule, extended release | 30 mg/1 | Aytu BioPharma, Inc. | CII |
| 0527-6582 | METADATE CD | capsule, extended release | 40 mg/1 | Lannett Company, LLC | CII |
| 69654-582 | METADATE CD | capsule, extended release | 40 mg/1 | Aytu BioPharma, Inc. | CII |
| 0527-6583 | METADATE CD | capsule, extended release | 50 mg/1 | Lannett Company, LLC | CII |
| 69654-583 | METADATE CD | capsule, extended release | 50 mg/1 | Aytu BioPharma, Inc. | CII |
| 0527-6584 | METADATE CD | capsule, extended release | 60 mg/1 | Lannett Company, LLC | CII |
| 69654-584 | METADATE CD | capsule, extended release | 60 mg/1 | Aytu BioPharma, Inc. | CII |
Questions
Is Metadate CD a controlled substance?
Yes. Metadate CD (methylphenidate) is a Schedule II controlled substance under the federal Controlled Substances Act. Matching DEA list entry: Methylphenidate (Schedule II).
Is Metadate CD a narcotic?
No. The DEA list does not mark methylphenidate as a narcotic (NARC = N) and places it in Schedule II. Its FDA established pharmacologic class is Central Nervous System Stimulant.
What schedule is Metadate CD?
Metadate CD is Schedule II in the FDA NDC directory, which matches the DEA controlled substances list.
Does this page cover state schedules?
No. This page reports the federal schedule only. Some states schedule drugs on their own; check your state board of pharmacy.
More on Metadate CD
- What is Metadate CD used for?FDA label uses
- Generic for Metadate CDFDA Orange Book
- What is Methylphenidate used for?FDA label uses
- Is Methylphenidate a controlled substance?Schedule II
- Generic for Aptensio XRFDA Orange Book
- Generic for Jornay PMFDA Orange Book
- Generic for Ritalin LAFDA Orange Book
- Generic for DaytranaFDA Orange Book
- Generic for Quillivant XRFDA Orange Book
- Generic for MethylinFDA Orange Book
- Generic for QuilliChew ERFDA Orange Book
- Generic for ConcertaFDA Orange Book
- Generic for RelexxiiFDA Orange Book
- Generic for Ritalin-srFDA Orange Book
- Generic for Cotempla XR-ODTFDA Orange Book
- Central Nervous System Stimulants listFDA drug class